| Target Price | €45.90 |
| Price | €35.20 |
| Potential |
30.40%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Neurones 2027 .
The average Neurones target price is €45.90.
This is
30.40%
register free of charge
€47.25
34.23%
register free of charge
€45.45
29.12%
register free of charge
|
|
| A rating was issued by 5 analysts: 4 Analysts recommend Neurones to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Neurones stock has an average upside potential 2027 of
30.40%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million € | 857.18 | 926.17 |
| 5.78% | 8.05% | |
| EBITDA Margin | 10.92% | 11.23% |
| 6.92% | 2.88% | |
| Net Margin | 6.07% | 6.10% |
| 6.34% | 0.42% |
2 Analysts have issued a sales forecast Neurones 2026 . The average Neurones sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an Neurones EBITDA forecast 2026. The average Neurones EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
2 Neurones Analysts have issued a net profit forecast 2026. The average Neurones net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share € | 2.14 | 2.32 |
| 0.93% | 8.41% | |
| P/E | 15.15 | |
| EV/Sales | 0.63 |
2 Analysts have issued a Neurones forecast for earnings per share. The average Neurones EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| ESN/CIC MARKET SOLUTIONS |
Locked
➜
Locked
|
Locked | Sep 10 2026 |
| ESN/CIC MARKET SOLUTIONS |
Locked
➜
Locked
|
Locked | Jun 18 2026 |
| ESN/CIC MARKET SOLUTIONS |
Locked
➜
Locked
|
Locked | Jun 17 2026 |
| ESN/CIC MARKET SOLUTIONS |
Locked
➜
Locked
|
Locked | Feb 12 2026 |
| ESN/CIC MARKET SOLUTIONS |
Locked
➜
Locked
|
Locked | Nov 06 2025 |
| ESN/CIC MARKET SOLUTIONS |
Locked
➜
Locked
|
Locked | Aug 07 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
ESN/CIC MARKET SOLUTIONS:
Locked
➜
Locked
|
Sep 10 2026 |
|
Locked
ESN/CIC MARKET SOLUTIONS:
Locked
➜
Locked
|
Jun 18 2026 |
|
Locked
ESN/CIC MARKET SOLUTIONS:
Locked
➜
Locked
|
Jun 17 2026 |
|
Locked
ESN/CIC MARKET SOLUTIONS:
Locked
➜
Locked
|
Feb 12 2026 |
|
Locked
ESN/CIC MARKET SOLUTIONS:
Locked
➜
Locked
|
Nov 06 2025 |
|
Locked
ESN/CIC MARKET SOLUTIONS:
Locked
➜
Locked
|
Aug 07 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


